Literature DB >> 9145861

Antibacterial activity of BMS-180680, a new catechol-containing monobactam.

J Fung-Tomc1, K Bush, B Minassian, B Kolek, R Flamm, E Gradelski, D Bonner.   

Abstract

The in vitro activities of a new catechol-containing monobactam, BMS-180680 (SQ 84,100), were compared to those of aztreonam, ceftazidime, imipenem, piperacillin-tazobactam, ciprofloxacin, amikacin, and trimethoprim-sulfamethoxazole. BMS-180680 was often the most active compound against many species of the family Enterobacteriaceae, with MICs at which 90% of the isolates were inhibited (MIC90s) of < or = 0.5 microg/ml for Escherichia coli, Klebsiella spp., Citrobacter diversus, Enterobacter aerogenes, Serratia marcescens, Proteus spp., and Providencia spp. BMS-180680 had moderate activities (MIC90s of 2 to 8 microg/ml) against Citrobacter freundii, Morganella morganii, Shigella spp., and non-E. aerogenes Enterobacter spp. BMS-180680 was the only antibiotic evaluated that was active against >90% of the Pseudomonas aeruginosa (MIC90, 0.25 microg/ml), Burkholderia cepacia, and Stenotrophomonas maltophilia (MIC90s, 1 microg/ml) strains tested. BMS-180680 was inactive against most strains of Pseudomonas fluorescens, Pseudomonas stutzeri, Pseudomonas diminuta, and Burkholderia pickettii. BMS-180680 was moderately active (MIC90s of 4 to 8 microg/ml) against Alcaligenes spp. and Acinetobacter lwoffii and less active (MIC90, 16 microg/ml) against Acinetobacter calcoaceticus-Acinetobacter baumanii complex. BMS-180680 lacked activity against gram-positive bacteria and anaerobic bacteria. Both tonB and cir fiu double mutants of E. coli had greatly decreased susceptibility to BMS-180680. Of the TEM, PSE, and chromosomal-encoded beta-lactamases tested, only the K1 enzyme hydrolyzed BMS-180680 to any measurable extent. Like aztreonam, BMS-180680 bound preferentially to penicillin-binding protein 3. The MICs of BMS-180680 were not influenced by the presence of hematin or 5% sheep blood in the test medium or with incubation in an atmosphere containing 5% CO2. BMS-180680 MICs obtained under strict anaerobic conditions were significantly higher than those obtained in ambient air.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145861      PMCID: PMC163842     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Role of permeability barriers in resistance to beta-lactam antibiotics.

Authors:  H Nikaido
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

2.  Purification of beta-lactamases on QAE-sephadex.

Authors:  G W Ross; M G Boulton
Journal:  Biochim Biophys Acta       Date:  1973-06-06

3.  Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units.

Authors:  E Maningo; C Watanakunakorn
Journal:  J Infect       Date:  1995-09       Impact factor: 6.072

4.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

5.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.

Authors:  R B Sykes; D P Bonner; K Bush; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

6.  Ferric citrate transport in Escherichia coli requires outer membrane receptor protein fecA.

Authors:  W Wagegg; V Braun
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

7.  Iron transport in Escherichia coli K-12. 2,3-Dihydroxybenzoate-promoted iron uptake.

Authors:  R E Hancock; K Hantke; V Braun
Journal:  Arch Microbiol       Date:  1977-09-28       Impact factor: 2.552

8.  Identification of an iron uptake system specific for coprogen and rhodotorulic acid in Escherichia coli K12.

Authors:  K Hantke
Journal:  Mol Gen Genet       Date:  1983

9.  In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.

Authors:  K Katsu; K Kitoh; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  Regulation of ferric iron transport in Escherichia coli K12: isolation of a constitutive mutant.

Authors:  K Hantke
Journal:  Mol Gen Genet       Date:  1981
View more
  14 in total

1.  Differences in sensitivity to PA-1806 among iron transport mutants of Pseudomonas aeruginosa compared to Escherichia coli.

Authors:  W R Schwan; L Barker; L L Brody
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 2.  Investigational antimicrobial agents of 2013.

Authors:  Michael J Pucci; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

3.  Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.

Authors:  Craig J McPherson; Lisa M Aschenbrenner; Brian M Lacey; Kelly C Fahnoe; Margaret M Lemmon; Steven M Finegan; Baswanth Tadakamalla; John P O'Donnell; John P Mueller; Andrew P Tomaras
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

Review 4.  Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.

Authors:  C M Perry; A Markham
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

Review 5.  Translational deficiencies in antibacterial discovery and new screening paradigms.

Authors:  Paul M Dunman; Andrew P Tomaras
Journal:  Curr Opin Microbiol       Date:  2015-09-08       Impact factor: 7.934

6.  Biochemical-genetic characterization and distribution of OXA-22, a chromosomal and inducible class D beta-lactamase from Ralstonia (Pseudomonas) pickettii.

Authors:  P Nordmann; L Poirel; M Kubina; A Casetta; T Naas
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

Review 7.  Biology of Pseudomonas stutzeri.

Authors:  Jorge Lalucat; Antoni Bennasar; Rafael Bosch; Elena García-Valdés; Norberto J Palleroni
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

8.  Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum.

Authors:  Samuel Bellais; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

9.  Involvement of Fe uptake systems and AmpC β-lactamase in susceptibility to the siderophore monosulfactam BAL30072 in Pseudomonas aeruginosa.

Authors:  Christian van Delden; Malcolm G P Page; Thilo Köhler
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

10.  Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa.

Authors:  Andrew P Tomaras; Jared L Crandon; Craig J McPherson; Mary Anne Banevicius; Steven M Finegan; Rebecca L Irvine; Matthew F Brown; John P O'Donnell; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.